CG
GRTX

Cutler Group’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Cutler Group’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-500
Closed – – 5449
2022
Q3 		$0 Sell
500
-1,100
-69% -$1.55K ﹤0.01% 5677
2022
Q2 		$2K Sell
1,600
-100
-6% -$171 ﹤0.01% 4423
2022
Q1 		$4K Buy
1,700
+100
+6% +$261 ﹤0.01% 4356
2021
Q4 		$7K Buy
+1,600
New +$5.29K ﹤0.01% 4007

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cutler Group's GRTX Position: Q4 2022 in Review

Cutler Group sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2022, closing a stake of 500 shares.

Cutler Group first reported a position in GRTX in Q4 2021 and held it in 4 quarters. The position peaked at $7K in Q4 2021. 32 funds tracked by Wall St. Rank hold GRTX as of Q4 2022.

  • Cutler Group reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 500 Galera Therapeutics, Inc. Common Stock shares in Q4 2022.
  • Cutler Group first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Cutler Group's Galera Therapeutics, Inc. Common Stock position peaked at $7K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.